malaria_record: 128

Data license: Public Domain (CDC) · Data source: CDC Travelers' Health (Yellow Fever & Malaria, by country)

This data as json

record_id country_id valid_from valid_to is_current source_id fetch_run_id payload_sha256 content_hash area_of_risk_html relative_risk_html chloroquine_resist_html species_html recommended_prophylaxis_html cdc_updated_date has_transmission is_endemic whole_country_endemic country_has_any_prophylaxis_area screening_class prophylaxis_drugs_json species_json chloroquine_resistant area_summary created_at
128 128 2026-06-03   1 1 1 8eab5796788447f748d742bc3ea9c689b7dd02e0761828d2fa9fd151f54f3515 cc1d8c47657288c18f2867d1dc09cc2f697d69af3c989e0a2eaa407a4c857a8b
  • All areas of eastern Indonesia (the provinces of Maluku, North Maluku, East Nusa Tenggara, Papua, and West Papua), including the town of Labuan Bajo and the Komodo Islands in the Nusa Tenggara region
  • Rural areas of Kalimantan (Borneo), West Nusa Tenggara (includes the island of Lombok), Sulawesi, and Sumatra
  • Low transmission in rural areas of Java, including Pangandaran, Sukabumi, and Ujung Kulon
  • No malaria transmission in the cities of Jakarta (the capital) or Ubud
  • No malaria transmission in the resort areas of Bali or Java, the Gili Islands, or the Thousand Islands (Pulau Seribu)
  
  • Chloroquine (P. falciparum and P. vivax)
  • P. falciparum (60%)
  • P. vivax (40%)
  • P. knowlesi,6 P. malariae, and P. ovale (rare)
  • Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine3
Updated April 23, 2025
 2025-04-23 1 1 0 1 partial ["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"] ["P. falciparum", "P. knowlesi", "P. malariae", "P. ovale", "P. vivax"] 1 3 risk area statement(s); 2 no-transmission exclusion(s) 2026-06-03T22:10:28Z

Links from other tables